Zenascope Aids in the Screening and Detection of Cervical Cancer in Developing Countries

Zenalux Biomedical, Inc. presented its latest findings on the investigational use of the Zenascope® in cervical cancer screening at the U.S. Investigators’ Symposium on Global Non-Communicable Disease Research. The poster—titled “Towards a viable solution for a see and treat paradigm for cervical pre-cancer screening in East Africa”—focused on the use of the Zenascope in cervical pre-cancer screening in East Africa where neither HPV testing nor Pap smears are routinely available. - October 10, 2014 - Zenalux Biomedical, Inc.

Starry Night Chicago Raises Funds to Help Kids with Brain Tumors

Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on childhood brain tumors, made its debut in Chicago on Oct. 4 with the support of more than 500 participants. At start time, the event had raised $46,000. The crowd came to the 8.5K at Arlington... - October 09, 2014 - Pediatric Brain Tumor Foundation

Green Biologics is Named in the 2014 Global Cleantech 100

List Recognises the Top Private Companies in Clean Technology - October 08, 2014 - Green Biologics Ltd

AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy

AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.

Colorado BioScience Association Promotes Colorado’s Medical Technology Industry, Along with Two of the State’s Economic Development Entities at AdvaMed 2014

Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will tout Colorado’s growing medical device and diagnostic sectors during the '2014 AdvaMed: The MedTech Conference' in Chicago, IL, October 6-8. - October 08, 2014 - Colorado BioScience Association

Colorado Institute for Drug, Device and Diagnostic Development Awards Funding & Management Assistance to Sapphire Technology

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Denver-based Sapphire Technology, LLC, to receive funding and management assistance. - October 07, 2014 - Colorado Institute for Drug, Device and Diagnostic Development

AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy

AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.

Ability of Semiconductor DNA Sequencing to Transform Healthcare and Save Lives Recognised by the 2014 Faraday Medal to Professor Chris Toumazou

DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, announces today that its founder, Chairman and CEO Professor Chris Toumazou FRS, FREng, FMEDSci, FIET, FIEEE, FCGI, FRSM has been... - October 04, 2014 - DNA Electronics

MoBiTec GmbH: PDE Inhibitors Show Sonic Effects on Prostate Cancer

In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined. - October 02, 2014 - MoBiTec GmbH

Bide Pharmatech Cooperates with 2 New Distributors in India and France

Bide Pharmatech, a leading pharmaceutical intermediate provider, has announced the signature of a new agreement with two distributors: Interchim in France and Prince Scientific & Surgicals in India. - September 30, 2014 - Bide Pharmatech Ltd.

GenapSys Announces Key Hire to Senior Management Team

GenapSys Announces Key Hire to Senior Management Team

Addition of Vice President Strengthens Application and Product Development of the GENIUS(tm) 110 DNA Sequencing system. - September 25, 2014 - Genapsys Inc.

Randomized Data Presented at International Headache Meeting (EHMTIC)) Shows Gammacore Significantly Reduces Cluster Headache Attack Frequency*

The biannual European Headache and Migraine Trust International Conference (EHMTIC) meeting concluded yesterday in Copenhagen, where more than 900 neurologists and other headache specialists came to hear about the latest advances in managing severe headache conditions, including electroCore’s... - September 25, 2014 - electroCore

New Osteology Book on Clinical Research - Get Your Copy at the EAO in Rome

At the EAO congress in Rome, the Osteology Foundation will present its second book of the series “Osteology Guidelines for Oral & Maxillofacial Regeneration.” The book from the editors William V. Giannobile, Niklaus P. Lang and Maurizio S. Tonetti focuses on Clinical Research, and will be available fresh from the press during the congress. - September 25, 2014 - Osteology Foundation

DNAe Completes Its Leadership Team with Key Operational and R&D Appointments as It Takes Forward Its DNA Diagnostic Test for Sepsis

DNA Electronics ("DNAe"), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, today announced the completion of its leadership team with the appointment of Kevin Stearn as Operational Director, and Dr David Edington as Vice President, R&D. - September 24, 2014 - DNA Electronics

Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership

Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners

Signed Robin Williams Skate Deck Part of Auction to Benefit PBTF

Actor and comedian Robin Williams was well-known for his philanthropy, especially for children’s causes. Just a few months before his death, he signed a skateboard to be included in an auction to help children with brain tumors. Williams worked with the skate deck’s artist, Cody Gallo,... - September 21, 2014 - Pediatric Brain Tumor Foundation

Primerdesign Open for £3000 Sponsored Student Scheme

Every year Primerdesign sponsors a number of postgraduate students across the UK. The sponsorship helps with their research by actively promoting good science and providing some free training and high quality real-time PCR kits and reagents. Projects are assessed and a number of sponsorships... - September 21, 2014 - Primerdesign Ltd

Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes

Pipette.com offers new promotions on micropipettes from major brands Sartorius/Biohit, Socorex, Capp, and AccuPet. The promotion is designed to help labs find the right pipette for their work and keep them within their budget. - September 20, 2014 - Pipette.com

Four Colorado Bioscience Companies Presented at the Inaugural White Hat Life Science Investor Conference in Phoenix

Four Colorado companies were selected to present at the 2014 "White Hat Life Science Investor Conference," in Phoenix, AZ. The Colorado companies included among the 34 presenting companies from across the region, were: EndoShape, Fluonic, ValveXchange and ViroCyt. - September 19, 2014 - Colorado BioScience Association

Newsletter XVII is Available from MoBiTec GmbH, Germany

MoBiTec's periodical Newsletter, issued several times a year, informs about new, exciting products in the categoríes vector systems and gene expression, genomics, proteomics, fluorescence applications, cell biology, labware, and more. - September 19, 2014 - MoBiTec GmbH

Creative Biomart Morning Talk for Mutagenesis Services

Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart

Pathology Diagnostics Ltd (PDL) Works Hand in Hand with Grants4Growth

Pathology Diagnostics Ltd is a highly successful SME which has recently expanded its facilities by moving to Stirling House business centre to a bespoke state-of-the-art pathology laboratory five times larger than its previous premises. As part of the company investment in the new facility, senior... - September 14, 2014 - Pathology Diagnostics Ltd

Colorado Medical Device Company, dBMEDx, Wins the Venture Showcase Competition at BioWest 2014

dBMEDx (Littleton, CO) won the Venture Showcase competition at the 2014 BioWest Conference & Expo, which is organized by the Colorado BioScience Association (CBSA). Three finalists competed for the $7,500 cash prize, presenting their technologies and business plans in front of a live audience to a panel of bioscience experts and venture capitalists. - September 13, 2014 - Colorado BioScience Association

Pathology Diagnostics Ltd (PDL) Company Growth Leads to Significant Premises Expansion

Pathology Diagnostics Ltd has experienced recent company growth in size and structure, moving to new premises with state of the art laboratory facilities in May 2012 – since then acquiring several more large office spaces, meeting rooms and conference room facilities (to see more please go to... - September 13, 2014 - Pathology Diagnostics Ltd

Pathology Diagnostics Ltd (PDL) Wins Prestigious Biomedical Catalyst (BMC) Scheme Award

Pathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round of the BMC scheme in December 2012. The... - September 12, 2014 - Pathology Diagnostics Ltd

VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Website, Omega-3 Summit at Supply Side West and CEO is Again Scheduled to Speak at Cal Poly Pomona

VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Website, Omega-3 Summit at Supply Side West and CEO is Again Scheduled to Speak at Cal Poly Pomona

VIRUN has been granted patent number 261124 titled, Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agents. Also, VIRUN has re-designed their website to include brands, a product description page, video as well as a news and PR page. Included in the newly renovated website is an events page; with the growing interest in VIRUN, such as scheduled forums, lectures, expos and webinars, it was imperative this new website share these experiences. - September 11, 2014 - VIRUN

F2G Limited, the UK-Based Antifungal Drug Discovery and Development Company, Announces a Major Funding Award from the Technology Strategy Board’s Biomedical Catalyst

F2G Limited, the UK-based antifungal drug discovery and development company, today announced a major funding award from the Technology Strategy Board’s Biomedical Catalyst. - September 11, 2014 - F2G Ltd

Creative Biomart Newly Introduced Its Stable Cell Line Service

Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative Biomart

Megan Driscoll, CEO of PharmaLogics Recruiting Becomes 1 of Only 750 Other Female CEO’s on the 2014 Inc. 5000 List of America’s Fastest-Growing Private Companies

Xeno Diagnostics Adds Dr. Daniel Wierda as Director of Research and Development

Addition of Top Talent Strengthens Fast-Growing Indianapolis Biotech CRO - September 10, 2014 - Xeno Diagnostics, LLC

No Pricks, No Sticks, No Pain - Hyperion Biotechnology’s Fatigue Testing Featured on Health-Briefs TV with Terry Bradshaw

Hyperion’s non-invasive saliva testing provides an objective measure of fatigue to help combat the risks associated with high fatigue levels in the workplace, in athletic programs, on the road, and on health. - September 07, 2014 - Hyperion Biotechnology, Inc.

Bioo Scientific Features Sensitive Food Safety Solutions for Aflatoxin M1 Analysis at AOAC 2014

At the 128th AOAC Annual Meeting, Bioo Scientific will showcase its sensitive solutions for aflatoxin M1 analysis: the MaxSignal® Aflatoxin M1 ELISA Kit, the AuroFlow™ Aflatoxin M1 Strip Test Kit and the AflaPure™ Aflatoxin M1 Column Kit, at booth #117. The 128th AOAC Annual Meeting will be held September 7-10 in Boca Raton, Florida. - September 07, 2014 - Bioo Scientific

Colorado BioScience Association Launches New “BioTalks” at BioWest 2014 in Denver; People Talking About Big, Bold Ideas

Colorado BioScience Association (CBSA) is introducing new BioTalk segments at BioWest 2014 in Denver. These are eight fast-paced presentations about the Big and Bold ideas in the Bio Industry. There are both morning and afternoon sessions of BioTalks scheduled. - September 06, 2014 - Colorado BioScience Association

F2G Ltd, the UK Antifungal Drug Discovery & Development Company, Today Announces Commencement of a Phase 1 Single Ascending Dose Study of a Novel Antifungal Agent

F2G Limited, the antifungal research and development company today announced a major milestone in the development of its novel IV/oral systemic antifungal (F901318) with the commencement of a Phase I clinical study. This study initiates the IV Phase I clinical development of F901318 with the oral... - September 04, 2014 - F2G Ltd

MoBiTec to Attend the 4. Joint Conference of the VAAM and DGHM in Dresden, Germany, Oct. 5-8, 2014

This year the DGHM (Society of Hygiene and Microbiology) and the VAAM (Association for General and Applied Microbiology), the biggest German societies in the area of microbiology, hold their annual conference as a joint conference in Dresden. - September 04, 2014 - MoBiTec GmbH

Cospheric Launches CosphericNano, Specializing in Precision Silica Nanospheres

Cospheric Launches CosphericNano, Specializing in Precision Silica Nanospheres

In an effort to provide customers in the nanotechnology industry with specialty nanomaterials, Cospheric LLC has added a selection of highly precise and spherical monodisperse silica nanospheres to their broad product line and launched CosphericNano – a website dedicated exclusively to... - September 03, 2014 - Cospheric LLC

BioWest Expo Showcases New Technologies, Products & Services for 300+ Attendees; Features FDA Commissioner Hamburg as Lead Keynote

Exhibitors will be showcasing new technologies, products and services for 300+ attendees at the 2014 BioWest Conference & Expo, September 10, at the Marriott City Center, Denver. Keynote speakers include Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office. - September 02, 2014 - Colorado BioScience Association

Creative Biomart Newly Released a Bunch of Over-Expression Lysates

Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative Biomart

MoBiTec, Germany, Offers Clickable Isoprenoids Manufactured by Echelon Biosciences, USA, Representing Exclusive Valuable Tools for Isoprenoid and Cancer Research

Isoprenoids are organic compounds composed of two or more units of hydrocarbons, with each unit consisting of five carbon atoms arranged in a specific pattern. Isoprenoids play widely varying roles in physiological processes of plants and animals. - August 31, 2014 - MoBiTec GmbH

Three Top Colorado Bioscience CEOs Confirmed to Present at the 2014 BioWest Conference & Expo

Colorado BioScience Association (CBSA) will host three of Colorado’s top CEOs at the "Colorado Companies: From Concept to Market" panel presentation on September 10th at the 2014 BioWest Conference & Expo. Participating CEO’s include: Bill Aldrich, EndoShape; David Brunel, Biodesix; and Byron Hewett, SomaLogic. - August 30, 2014 - Colorado BioScience Association

Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com

Eppendorf Safe Lock Centrifuge Tubes provide the perfect seal and evaporation protection, ensuring sample protection and yielding the best results. - August 30, 2014 - Pipette.com

Mac’s SET the PACE Race Superhero for a Day 5K Run/Walk

Join the Mac’s SET the PACE Race at Washington Park in Denver, CO. This event honors patients, survivors and their family members. Increasing awareness of prostate cancer and the importance of early detection with a fun day of activities for the whole family. - August 29, 2014 - Prostate Conditions Education Council

Pathology Diagnostics Ltd Contributes as Expert Advisor to Groundbreaking Medical Research Council (MRC) Review of UK Molecular Pathology Services

The MRC has recently published a thought provoking and comprehensive review of molecular pathology capabilities in the United Kingdom in R&D and healthcare. The UK government and research charities (TSB, MRC, NIHR, CRUK, Arthritis UK) are collectively investing £200 million in the field of molecular pathology via the Stratified Medicine Innovation Platform (SMIP). Pathology Diagnostics Ltd lent their expertise as expert advisors to the review. - August 29, 2014 - Pathology Diagnostics Ltd

MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR Kit

Ebola hemorrhagic fever (Ebola HF) is a severe, often fatal disease in humans and nonhuman primates, caused by infection with Ebolavirus. The recent Ebola outbreak in West Africa is one of the largest Ebola outbreaks in history. - August 28, 2014 - MoBiTec GmbH

NC COIN Promotes Karen Shank to Business Development Director

Pharma, Software, and Medical Technology Veteran Developing K-12 Programming, Expanding Membership Base of Nonprofit Idea Accelerator - August 27, 2014 - COIN

Creative Biomart Introduced Immobilized Enzyme Service

On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart

Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference

Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC

MoBiTec GmbH to Attend Horizons in Molecular Biology Meeting in Goettingen, Germany, Sep 15-18, 2014

Horizons in Molecular Biology is an international symposium in the field of molecular life sciences, organized by PhD students of the MSc/PhD Molecular Biology Program - International Max Planck Research School (IMPRS). - August 24, 2014 - MoBiTec GmbH

Primerdesign Launch World’s Most Affordable DNA Testing System

Primerdesign Ltd is excited to announce the release of the World’s Most Affordable DNA Testing System. The genesig q16 accompanies a catalogue of over 400 easy to use DNA testing kits which encompass a range of practical applications. DNA testing is versatile and has a huge range of practical... - August 23, 2014 - Primerdesign Ltd

Creative Biomart Launches Novel Service for Protein Labeling

On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart

Press Releases 1,151 - 1,200 of 3,213